| http://www.w3.org/ns/prov#value | - The disease is often resistant to treatments such as chemotherapy and radiation and median survival is approximately 15 months from the point of first diagnosis. ???Improving the survival for GBM patients is an important goal for many of us here at Northwestern,??? said the study???s principal investigator Andrew Parsa, MD, PhD who is chair of neurological surgery at Northwestern Memorial Hospital
|
